Evidence map›Paper›PMID 34410311›Full record

Trial reportJAMA ophthalmology2021

Choice of Dose Level for a Randomized Clinical Trial of Low-Dose Bevacizumab vs Laser for Type 1 Retinopathy of Prematurity.

Raymond T Kraker, David K Wallace, Roy W Beck, Christina T Saunders, Elizabeth Lorenzi, B Michele Melia, Zhuokai Li, Pediatric Eye Disease Investigator Group

Registry-linked trialAbstract readLetterRandomized Controlled Trial
PubMed Full text at PMC Publisher
In one paragraph

Trial report in JAMA ophthalmology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02390531 (Phase 1 Trial of Bevacizumab Treatment for Severe Retinopathy of Prematurity), which is not on this map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02390531 phase1completednot on this map

Phase 1 Trial of Bevacizumab Treatment for Severe Retinopathy of Prematurity

TypeinterventionalSponsorJaeb Center for Health ResearchRan2015 to 2021Enrolled120ConditionsRetinopathy of PrematurityArmsBevacizumab
3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors.

Raymond T KrakerJaeb Center for Health Research, Tampa, Florida.
David K WallaceIndiana University Department of Ophthalmology, Indianapolis.
Roy W BeckJaeb Center for Health Research, Tampa, Florida.
Christina T SaundersBerry Consultants, Austin, Texas.
Elizabeth LorenziBerry Consultants, Austin, Texas.
B Michele MeliaJaeb Center for Health Research, Tampa, Florida.
Zhuokai LiJaeb Center for Health Research, Tampa, Florida.
Pediatric Eye Disease Investigator Group

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Retinopathy of PrematurityAngiogenesis InhibitorsBevacizumabGestational AgeHumansInfant, NewbornIntravitreal InjectionsLaser CoagulationLasersAngiogenesis InhibitorsBevacizumab

Identifiers

PMID34410311
PMCPMC8377606

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.